News and Trends 7 Feb 2023
Antibody candidate for treating serious liver disease
…a new method for limiting the development of fatty liver. For the study, the researchers had access to a drug candidate in the form of an antibody to the protein…
Search Results for: Antibody candidate
Best in Biotech 19 Nov 2024
Six bispecific antibody companies you should know about
…The bispecific antibody company is currently working with Summit Therapeutics on the development of ivonescimab. The candidate, originally discovered by Akeso, combines the power of immunotherapy through a blockade of…
2024 biotech deals tracker: the latest partnerships and M&A
…cash, and the lead asset acquired is a monoclonal antibody for inflammatory bowel disease. July 2024: Sionna Therapeutics, based in the United States, has partnered with AbbVie, also a U.S….
In Depth 18 Sep 2024
Two targets, one solution: The rise of bispecific antibodies
…just recently regarding its relapsed or refractory multiple myeloma bispecific candidate, linvoseltamab, after the FDA rejected its filing for approval for the candidate, issuing a complete response letter due to…
ADVERTISEMENT
Best in Biotech 22 Jan 2025
Curing ALS? Sixteen companies developing new treatments in 2025
…Alchemab Therapeutics (in collaboration with Eli Lilly) Technology: B-cells sequencing Candidates: Multiple antibodies Recent news: Collaboration with Eli Lilly to develop ALS candidates Alchemab Therapeutics is a U.K.-based biopharmaceutical company…
Best in Biotech 30 Jan 2024
Navigating German biotech: 13 key players to know
…monoclonal antibody candidate. This is being developed in collaboration with OncoC4, Inc., and is currently in a pivotal phase 3 trial for patients with non-small cell lung cancer (NSCLC) who…
Best in Biotech 18 Mar 2025
Cancer vaccines: 11 biotechs to keep an eye out for
…of Washington and Fred Hutchinson Cancer Research Center. In a study, the candidate showed a favorable safety profile, and patients showed encouraging immunological responses. Another clinical candidate of Immunomic is…
Best in Biotech 11 Jan 2024
Ten NK cell therapy companies to look out for this year
…therapy that is designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of monoclonal antibodies. This way, the drug can kill auto-antibody producing B cells. The candidate is also being…
News and Trends 16 Nov 2022
Bio-Rad introduces pioneer antibody discovery platform for therapeutic development
…display library engineered to include more than 200 billion unique sequences and capable of identifying high-affinity antibody candidates using Bio-Rad’s newly developed SpyDisplay selection technology. The Pioneer antibody library is…
Weekly Roundup 8 Dec 2023
Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer
…pan‑immunoglobulin (Ig) G protease sculpting (Sc) enzyme candidate (S-1117) and a PD-1 agonist:Fc gamma receptor IIb selective Dual-cell Bidirectional (DcB) antibody candidate (S-4321). The fundraising will also allow Seismic to…
Best in Biotech 22 Apr 2025
Seven biotechs to watch in the hepatitis B space
…its pipeline when it went public for $110.5 million in May 2021. Bluejay Therapeutics Therapeutic candidate: BJT-778 Technology: monoclonal antibody Recent funding: $182 million series C Another California-based biotech, Bluejay Therapeutics,…
Best in Biotech 7 Nov 2023
Eight biotech companies tackling infectious diseases head-on
…designation from the EMA, the company looks to submit its candidate for regulatory approval next year. Moreover, Bavarian Nordic has other vaccine candidates in the mix. MVA-BN WEV is being…
